Nuclear Extraction Kit - Soluble / Insoluble Fractions
Be the first to review this product! Submit a review
|
(8 Publications)
- Used to extract soluble nuclear proteins, insoluble nuclear proteins and cytoplasmic proteins from adherent cells, suspension cells and tissue samples
- Kit contains reagents for 100 extractions
- SDS-PAGE
Supplier Data
SDS-PAGE - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
Extracts were prepared from 5 x 106 HeLa (human epithelial cell line from cervix adenocarcinoma) cells using Nuclear Extract Kit ab219177 and analysed by SDS-PAGE with Coomasie Blue staining. Extract or whole cell lysate from 3 x 104 cells was loaded in each lane along with BSA standards. Lanes : 1. MW marker; 2. Whole cell lysate; 3. Cytoplasmic extract; 4. Nuclear extract 1; 5. Nuclear extract 2; 6. MW marker; 7. BSA, 2.0 μg; 8. BSA 1.0 μg; 9. BSA 0.5 μg; 10. BSA 0.2 μg; 11. BSA 0.1 μg.
- FuncS
Supplier Data
Functional Studies - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
Extracts were prepared from 5 x 106 HeLa (human epithelial cell line from cervix adenocarcinoma) cells using Nuclear Extract Kit ab219177. Note that protease inhibitors were omitted from all buffers to prevent interference with the HDAC activity assay. The enzymatic activity of HDACs in each fraction was measured using the Histone Deacetylase (HDAC) Activity Assay Kit (Fluorometric) (ab156064). Extract from of 3 x 104 cells was used per assay test.
- sELISA
Supplier Data
Sandwich ELISA - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
NFkB p50 activity in treated and untreated Hela nuclear extract.
Nuclear extracts from Hela cells and Hela cells treated with 25 ng/mL TNF alpha were assayed from 0.1875 µg-12 µg/well using the Abcam NFkB p50 Transcription Factor Activity Assay. Data shown is from wells assayed in duplicate. Comparison of treated to untreated Hela nuclear extract shows average fold change ~17. ab219177 Nuclear Extraction kit was used to extract nuclear proteins.
- WB
Supplier Data
Western blot - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
Comparison of nuclear extraction from different cell lines.
Extracts were prepared from 5 x 106 cells from RAJI (human lymphoblastoid cell line), HEK-293 (human embryonic kidney cell line), SHSY-5Y (human neuroblastoma cell line) and U87-MG (human glioblastoma cell line) cell lines using Nuclear Extract Kit ab219177 and analysed by Western blot. Extract from 3 x 104 cells was loaded per lane.
false
- WB
Supplier Data
Western blot - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
Extracts were prepared from HeLa (human epithelial cell line from cervix adenocarcinoma) cells using the manufacturer's protocol and analyzed by Western blot. For each manufacturer : (1) cytoplasmic extract, (2) nuclear extract, (3) nuclear extract 2 or resolubilized insoluble nuclear fraction.
false
- WB
Supplier Data
Western blot - Nuclear Extraction Kit - Soluble / Insoluble Fractions (AB219177)
Comparison of nuclear extraction from different tissues.
Extracts were prepared from 120 mg of mouse tissue using Nuclear Extract Kit ab219177 and analysed by Western blot. Extract from 0.4 mg of tissue was loaded per lane.
false
Product details
Nuclear extraction kit ab219177 offers a simple 45 minute method for extracting nuclear proteins from mammalian cells or tissues.
For optimal extraction of nuclear proteins, the kit produces three distinct extracts (fractions): soluble nuclear proteins (nuclear extract 1), nuclear proteins that remain insoluble after production of nuclear extract 1 (nuclear extract 2), and cytoplasmic proteins.
The kit contains reagents for 100 extractions, where each extraction starts with 5 x 106 cells or 50 mg of tissue. Typical yields from each extraction are 0.3 – 0.4 mg of soluble nuclear proteins, 0.1 – 0.2 mg of insoluble nuclear proteins and 0.6 – 0.7 mg of cytoplasmic proteins. Nuclear proteins extracted with this kit can be used in a variety of applications such as western blotting and nuclear enzyme assays.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine (Cambridge, Mass.) 30:180 PubMed39425013
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:562 PubMed37626062
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 55:45-60 PubMed36828120
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:7408 PubMed36456565
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 60:1915-1924 PubMed36205592
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:3252 PubMed32591534
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:3420 PubMed30143639
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 293:14723-14739 PubMed30061153
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com